TearScience, Inc. Announces First U.S.-Based Eye Care Practice, Carolina Vision Center, to Offer LipiFlow(R) Treatment

Published: Oct 14, 2011

MORRISVILLE, N.C.--(BUSINESS WIRE)--TearScience, Inc., a privately-held medical device company, today announced that Fayetteville, North Carolina-based Carolina Vision Center, is the first eye care center in United States to commercially offer the LipiFlow® Thermal Pulsation System, a breakthrough treatment for evaporative dry eye disease. TearScience’s LipiFlow is designed to address meibomian gland dysfunction, allowing for the treatment of eyelid gland blockages during a non-invasive procedure administered at an eye care office. Opening the blocked eyelid glands allows the glands to resume the natural production of lipids (oils) needed for a healthy tear film. TearScience received U.S. FDA clearance for its LipiFlow® medical device on June 28, 2011.

Back to news